Quick Search

 

 


 

 

Home > Result Summaries: Compounds > ropinirole > Result Summary for 101468/196

Result Summary for 101468/196

Result Summary
Protocol ID: 101468/196
Clinical Study ID: 101468/196
Official Title: 101648/196: A Long-Term, Open-Label Continuation Study of Once Daily Administration of Ropinirole CR Tablets to Patients with Parkinson's Disease who Completed the Previous Ropinirole CR Studies 167 or 164
Phase: phase 3
Study Indications or Diseases:
  • Parkinson Disease
Generic Name: ropinirole
Trade/Product Name: Zygara,ZIPEREVE,ZEPREVE,Requip Depot,REQUIP,REPREVE,Modutab,ADARTREL
Approved Drug Label: http://www.gsk.com/products.html
Results Summary: Click here to download result summary. Click here to download result summary.
Citations:
  • Robert A. Hauser, Heinz Reichmann, Mark Lew, Afsaneh Asgharian, Clare Makumi, Kenneth Shulman. Long-term, open-label study of once-daily ropinirole prolonged release in early Parkinson’s disease. [Int J Neurosci]. 2011;Online.

The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.